[The role of tissue factor pathway inhibitor (TFPI) in thrombotic complications].
Gosk-Bierska
Izabela
I
Katedra i Klinika Angiologii, Nadciśnienia Tetniczego i Diabetologii Akademii Medycznej we Wrocławiu.
Adamiec
Rajmund
R
D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology*; D001777:Blood Coagulation / Q000187:drug effects*; D006801:Humans; D008074:Lipoproteins / Q000378:metabolism* / Q000627:therapeutic use*; D051379:Mice; D013927:Thrombosis / Q000188:drug therapy*; D020246:Venous Thrombosis / Q000188:drug therapy
D000925:Anticoagulants; D008074:Lipoproteins; C051928:lipoprotein-associated coagulation inhibitor